Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women With Vaginal Atrophy
Cairo University
20 participants
Oct 1, 2023
INTERVENTIONAL
Conditions
Summary
Vaginal dryness, itching, burning, irritability, secretion, and various urinary problems are the symptoms of vulvovaginal atrophy. Therefore, more attention must be paid to relieve these symptoms in order to provide better sexual health for postmenopausal women. At present, an accumulating body of evidence suggests safety and efficacy of laser and energy-based devices for the treatment of women's genitourinary conditions. More clinical studies are needed to assess the safety profile and clinical outcomes of the lasers and energy-based devices to treat the symptoms associated with vulvovaginal atrophy (VVA)
Eligibility
Inclusion Criteria3
- Menopausal women whose ages ranged from 45 to 65 years.
- Sexually active
- Had symptoms of VVA (vaginal dryness, irritation, soreness, or dyspareunia)
Exclusion Criteria8
- Any history of hormonal therapy within the past 6 months
- Vaginal moisturizer or lubricant applications within the past 30 days
- Acute/recurrent urinary tract infection
- Active genital infection
- Prolapse stage II or more based on examination
- Psychiatric disorders
- Undiagnosed vaginal bleeding
- Any serious disease or chronic condition that could interfere with study compliance
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
. Using the following settings with the internal handpiece: square pattern with Deep Mode, fractional density of 5% and energy level of 50 mJ and fluence of 283 J/cm2. The handpiece will be inserted into the vagina (up to 10 cm) The handpiece will be positioned with contact to the vagina and will be rotated to apply 12 pulses at each 1-cm marking (application of laser energy at 3-10-cm depths) until the distal end of the vaginal probe reaches the introitus. The laser application will be performed on an outpatient basis without local anesthesia in outpatient clinic.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06726746